Difficulty walking: Trouble initiating movement or maintaining a steady gait.
Masklike expression: Reduced facial expression, resulting in a 'mask-like' appearance.
Slurred speech: Impaired speech clarity and articulation.
Neurotransmitters Involved in Parkinson's Disease
Dopamine:
- Function: Plays a crucial role in how pleasure is experienced and is integral to cognitive functions such as thinking and planning.
- Pathophysiology: Death of neurons that produce dopamine leads directly to the symptoms of Parkinson’s disease.
Acetylcholine:
- Characteristics: It is the chief neurotransmitter of the parasympathetic nervous system. It is responsible for contracting smooth muscles, dilating blood vessels, increasing bodily secretions, and slowing the heart rate.
- Excessive acetylcholine activity due to low dopamine levels contributes to the symptoms experienced in Parkinson's disease.
Disease Progression
Mechanism: The following events contribute to the progression of Parkinson’s disease:
- Decrease in dopamine levels in the brain leads to an increase in acetylcholine activity.
- This imbalance of neurotransmitters results in the variety of symptoms associated with the disease.
Pathway: The communication pathway involving the neuromuscular junction shows how acetylcholine at the presynaptic membrane interacts with the receptor on the postsynaptic cell, where acetylcholinesterase (AChE) plays a significant role in degradation, thereby affecting motor function.
Pathophysiology of Parkinson’s Disease
Affected Areas: Symptoms are particularly related to damaged neurons located in the basal ganglia.
Theories Regarding Degeneration: Possible causes for neuron degeneration include:
- Viral infections.
- Blows to the head.
- Brain infections.
- Atherosclerosis.
- Environmental factors or drug exposure.
Treatment Goals
Restore the balance of dopamine in the brain.
Improve patient mobility and quality of movement.
Provide psychological support.
Help patients maintain independence, which includes:
- Staying as active as possible.
- Engaging in regular exercise.
- Managing their own care for as long as feasible.
- Adhering to prescribed medication regimens.
Dopaminergic Drugs
Common Medications
Amantadine (Gocovri, Osmolex ER)
Apomorphine (Apokyn)
Bromocriptine (Parlodel)
Levodopa (Inbrija)
Carbidopa–levodopa (Duopa, Rytary)
Pramipexole (Mirapex, Mirapex ER)
Rasagiline (Azilect)
Ropinirole (Requip, Requip ER)
Rotigotine (Neupro)
Entacapone
Levodopa: Key Drug
Mechanism of Action: Levodopa is utilized because dopamine itself cannot cross the blood-brain barrier. Levodopa alleviates motor symptoms by being converted to dopamine in the remaining active nerve terminals in the striatum.
- Enzyme Involved: The decarboxylase enzyme facilitates this conversion of levodopa to dopamine.
Side Effects: Common side effects include nausea, vomiting, and dark-colored urine. Adverse effects may encompass dyskinesia, postural hypotension, and psychosis.
Patient Education: Increased salt and water intake can mitigate hypotension. An alpha-adrenergic agonist may also be beneficial. Patients should be cautious of food interactions—specifically, high-protein foods can hinder absorption of levodopa.
Dopaminergic Drugs Pharmacokinetics
Absorption: Generally well absorbed from the gastrointestinal (GI) tract and broadly distributed throughout the body.
Metabolism: Primarily metabolized in the liver and peripheral tissues.
Excretion: Excreted via urine.
Crossing Barriers: These drugs can cross the placenta and are present in human breast milk.
Contraindications
Exclude use in scenarios where patients have demonstrated:
- Known allergies.
- Angle-closure glaucoma.
- Current lactation.
- Patients currently on or who have recently taken a nonselective MAOI.
Cautions
Special considerations should be made for patients with:
- Cardiovascular disease.
- Bronchial asthma.
- History of peptic ulcers.
- Urinary tract obstructions.
- Psychiatric disorders.
- Pregnant women.
Adverse Effects
These drugs are associated with multiple adverse effects affecting:
- Central Nervous System (CNS)
- Peripheral systems
- Potential for bone marrow depression
- Possible hepatic dysfunction
Drug-Drug Interactions
Care must be taken to avoid interactions with:
- MAOIs
- Over-the-counter (OTC) vitamins
- Iron salts particularly with carbidopa–levodopa
- Foods containing tyramine with rasagiline (notably certain aged cheeses and wines), St. John’s wort, meperidine, and acetaminophen.
Conclusion on Parkinson’s Disease Management
The condition is characterized by significantly low levels of dopamine.
The primary goal of treatment is to enhance and sustain dopamine levels in the brain.
While there is no definitive cure, medications can provide symptom relief and help delay further cognitive deterioration.
Administration Routes: Available in PO, IM, or IV (only for dystonia).
Mechanism: Cogentin selectively blocks central cholinergic receptors, balancing dopaminergic activity to lessen the severity of symptoms.
Indications: Effective in treating Parkinson’s disease and drug-induced extrapyramidal reactions.
Monitoring: It is crucial to assess elderly patients for signs such as confusion, disorientation, agitation, and psychotic-like symptoms, as well as monitoring for drowsiness, dry mouth, blurred vision, urinary retention, constipation, and gastrointestinal upset.
Anticholinergic Agents
Therapeutic Actions: These drugs exhibit a heightened affinity for central nervous system receptors compared to those in the peripheral nervous system, making them effective for treating parkinsonism and alleviating symptoms of extrapyramidal disorders triggered by certain medications.
Pharmacokinetics of Anticholinergics
Absorption and Metabolism: Anticholinergic drugs are variably absorbed through the GI tract, undergo metabolic processes primarily in the liver, and are eliminated through cellular routes. They also cross the placenta and can enter human milk.
Drugs should be avoided in individuals who have:
- Allergy to anticholinergics.
- Narrow-angle glaucoma or gastrointestinal or genitourinary obstruction.
- Conditions like prostatic hypertrophy, myasthenia gravis, tachycardia, dysrhythmias, hypertension, or hepatic dysfunction.
Adverse Effects of Anticholinergic Agents
Adverse effects can include CNS effects, various peripheral symptoms, tachycardia, urinary retention, and hesitancy. Monitoring for drug interactions with other anticholinergics and antipsychotics is also essential.
Adjunctive Agents
Importance: These are used to enhance the efficacy of traditional Parkinson's therapies.
Common Adjunct Drugs
Entacapone (Comtan) - Used with carbidopa–levodopa to boost levodopa plasma levels and duration of action.
Safinamide (Xadago) - Advised for use with carbidopa–levodopa in patients experiencing “off” episodes.
Selegiline (Eldepryl) - Applied when patients show diminishing responses to carbidopa–levodopa.
Tolcapone (Tasmar) - Works alongside carbidopa–levodopa to further augment levodopa plasma concentrations.
Nursing Responsibilities
Key Actions
Assessment: Regularly evaluate patients for side effects and therapeutic efficacy.
Education: Provide thorough education to patients regarding their medication regimens, potential side effects, and the importance of adherence to treatment protocols.
NCLEX Takeaways
Low Dopamine: Recognize the core issue in patients with Parkinson’s disease being a lack of dopamine.
Levodopa: The principal medication utilized in managing symptoms.
Falls Risk: A crucial consideration in patient assessments and management plans. Monitor for potential falls and encourage preventive measures.
Assessment: Thorough initial assessment of the patient is critical to tailor the treatment effectively.